19 related articles for article (PubMed ID: 30345020)
1. Relationship of Toll-Like Receptor 7, 9, and 10 Polymorphisms and the Severity of Coronavirus Disease 2019.
Bayyurt B; Baltacı S; Şahin NÖ; Arslan S; Bakır M
Jpn J Infect Dis; 2024 May; 77(3):161-168. PubMed ID: 38296538
[TBL] [Abstract][Full Text] [Related]
2. Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis.
Chen Z; Wang W; Liang J; Wang J; Feng S; Zhang G
BMC Pulm Med; 2015 May; 15():57. PubMed ID: 25948535
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors.
Sanders MS; van Well GT; Ouburg S; Morré SA; van Furth AM
BMC Infect Dis; 2012 May; 12():112. PubMed ID: 22577991
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.
Lai ZZ; Ni-Zhang ; Pan XL; Song L
J Int Med Res; 2013 Aug; 41(4):1027-36. PubMed ID: 23816930
[TBL] [Abstract][Full Text] [Related]
5. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.
Pandey S; Mittal B; Srivastava M; Singh S; Srivastava K; Lal P; Mittal RD
Mol Biol Rep; 2011 Oct; 38(7):4715-21. PubMed ID: 21132533
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
9. Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer.
Chauhan A; Pandey N; Raithatha N; Patel P; Desai A; Jain N
F1000Res; 2018; 7():606. PubMed ID: 30345020
[No Abstract] [Full Text] [Related]
10. TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study.
Wang D; Zhang C; Zhou Z; Pei F
Rheumatol Int; 2016 Apr; 36(4):585-95. PubMed ID: 26643792
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]